233 related articles for article (PubMed ID: 20842559)
1. Treatment of angina and microvascular coronary dysfunction.
Samim A; Nugent L; Mehta PK; Shufelt C; Bairey Merz CN
Curr Treat Options Cardiovasc Med; 2010 Aug; 12(4):355-64. PubMed ID: 20842559
[TBL] [Abstract][Full Text] [Related]
2. Enhanced External Counterpulsation (EECP): An Evidence-Based Analysis.
Medical Advisory Secretariat
Ont Health Technol Assess Ser; 2006; 6(5):1-70. PubMed ID: 23074496
[TBL] [Abstract][Full Text] [Related]
3. Safety of coronary reactivity testing in women with no obstructive coronary artery disease: results from the NHLBI-sponsored WISE (Women's Ischemia Syndrome Evaluation) study.
Wei J; Mehta PK; Johnson BD; Samuels B; Kar S; Anderson RD; Azarbal B; Petersen J; Sharaf B; Handberg E; Shufelt C; Kothawade K; Sopko G; Lerman A; Shaw L; Kelsey SF; Pepine CJ; Merz CN
JACC Cardiovasc Interv; 2012 Jun; 5(6):646-53. PubMed ID: 22721660
[TBL] [Abstract][Full Text] [Related]
4. Microvascular coronary dysfunction in women: pathophysiology, diagnosis, and management.
Kothawade K; Bairey Merz CN
Curr Probl Cardiol; 2011 Aug; 36(8):291-318. PubMed ID: 21723447
[TBL] [Abstract][Full Text] [Related]
5. Recent advances in the management of chronic stable angina II. Anti-ischemic therapy, options for refractory angina, risk factor reduction, and revascularization.
Kones R
Vasc Health Risk Manag; 2010 Sep; 6():749-74. PubMed ID: 20859545
[TBL] [Abstract][Full Text] [Related]
6. Nonacute coronary syndrome anginal chest pain.
Agarwal M; Mehta PK; Bairey Merz CN
Med Clin North Am; 2010 Mar; 94(2):201-16. PubMed ID: 20380951
[TBL] [Abstract][Full Text] [Related]
7. Ranolazine improves angina in women with evidence of myocardial ischemia but no obstructive coronary artery disease.
Mehta PK; Goykhman P; Thomson LE; Shufelt C; Wei J; Yang Y; Gill E; Minissian M; Shaw LJ; Slomka PJ; Slivka M; Berman DS; Bairey Merz CN
JACC Cardiovasc Imaging; 2011 May; 4(5):514-22. PubMed ID: 21565740
[TBL] [Abstract][Full Text] [Related]
8. Angina with "normal" coronary arteries: a changing philosophy.
Bugiardini R; Bairey Merz CN
JAMA; 2005 Jan; 293(4):477-84. PubMed ID: 15671433
[TBL] [Abstract][Full Text] [Related]
9. API expert consensus document on management of ischemic heart disease.
Association of Physicians of India
J Assoc Physicians India; 2006 Jun; 54():469-80. PubMed ID: 16909697
[TBL] [Abstract][Full Text] [Related]
10. In women with symptoms of cardiac ischemia, nonobstructive coronary arteries, and microvascular dysfunction, angiotensin-converting enzyme inhibition is associated with improved microvascular function: A double-blind randomized study from the National Heart, Lung and Blood Institute Women's Ischemia Syndrome Evaluation (WISE).
Pauly DF; Johnson BD; Anderson RD; Handberg EM; Smith KM; Cooper-DeHoff RM; Sopko G; Sharaf BM; Kelsey SF; Merz CN; Pepine CJ
Am Heart J; 2011 Oct; 162(4):678-84. PubMed ID: 21982660
[TBL] [Abstract][Full Text] [Related]
11. Sex-specific factors in microvascular angina.
Sedlak T; Izadnegahdar M; Humphries KH; Bairey Merz CN
Can J Cardiol; 2014 Jul; 30(7):747-755. PubMed ID: 24582724
[TBL] [Abstract][Full Text] [Related]
12. Microvascular Coronary Dysfunction-an Overview.
Naderi S
Curr Atheroscler Rep; 2018 Jan; 20(2):7. PubMed ID: 29383530
[TBL] [Abstract][Full Text] [Related]
13. Treatment of coronary microvascular dysfunction.
Bairey Merz CN; Pepine CJ; Shimokawa H; Berry C
Cardiovasc Res; 2020 Mar; 116(4):856-870. PubMed ID: 32087007
[TBL] [Abstract][Full Text] [Related]
14. Impact of Abnormal Coronary Reactivity on Long-Term Clinical Outcomes in Women.
AlBadri A; Bairey Merz CN; Johnson BD; Wei J; Mehta PK; Cook-Wiens G; Reis SE; Kelsey SF; Bittner V; Sopko G; Shaw LJ; Pepine CJ; Ahmed B
J Am Coll Cardiol; 2019 Feb; 73(6):684-693. PubMed ID: 30765035
[TBL] [Abstract][Full Text] [Related]
15. Coronary microvascular reactivity to adenosine predicts adverse outcome in women evaluated for suspected ischemia results from the National Heart, Lung and Blood Institute WISE (Women's Ischemia Syndrome Evaluation) study.
Pepine CJ; Anderson RD; Sharaf BL; Reis SE; Smith KM; Handberg EM; Johnson BD; Sopko G; Bairey Merz CN
J Am Coll Cardiol; 2010 Jun; 55(25):2825-32. PubMed ID: 20579539
[TBL] [Abstract][Full Text] [Related]
16. A randomized, placebo-controlled trial of late Na current inhibition (ranolazine) in coronary microvascular dysfunction (CMD): impact on angina and myocardial perfusion reserve.
Bairey Merz CN; Handberg EM; Shufelt CL; Mehta PK; Minissian MB; Wei J; Thomson LE; Berman DS; Shaw LJ; Petersen JW; Brown GH; Anderson RD; Shuster JJ; Cook-Wiens G; Rogatko A; Pepine CJ
Eur Heart J; 2016 May; 37(19):1504-13. PubMed ID: 26614823
[TBL] [Abstract][Full Text] [Related]
17. Women and Ischemic Heart Disease: Recognition, Diagnosis and Management.
Park SM; Merz CN
Korean Circ J; 2016 Jul; 46(4):433-42. PubMed ID: 27482251
[TBL] [Abstract][Full Text] [Related]
18. Current medical management of chronic stable angina.
Thadani U
J Cardiovasc Pharmacol Ther; 2004 Sep; 9 Suppl 1():S11-29; quiz S98-9. PubMed ID: 15378129
[TBL] [Abstract][Full Text] [Related]
19. Opium addiction as an independent risk factor for coronary microvascular dysfunction: A case-control study of 250 consecutive patients with slow-flow angina.
Esmaeili Nadimi A; Pour Amiri F; Sheikh Fathollahi M; Hassanshahi G; Ahmadi Z; Sayadi AR
Int J Cardiol; 2016 Sep; 219():301-7. PubMed ID: 27343424
[TBL] [Abstract][Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
